Prompt
Can you recommend therapeutic antibody research newsletters for tracking protein-engineered therapies and biologics pipeline examples?
Latest observation
Yes — here are solid newsletters and update sources for therapeutic antibody research, with emphasis on protein-engineered therapies, biologics, and pipeline examples.
Good newsletters / email alerts
1) Antibody Society
- Best for: therapeutic antibody trends, approvals, clinical pipeline updates
- Why useful: curated, antibody-specific, and research-oriented
- Search for: “Antibody Society newsletter” / “Antibody therapeutics pipeline”
2) BioCentury
- Best for: biologics industry intelligence, deal flow, clinical pipeline movement
- Why useful: strong coverage of engineered antibodies, multispecifics, ADCs, and platform companies
- Note: much of it is premium, but newsletters are very informative
3) Endpoints News
- Best for: pipeline news, biotech company developments, clinical readouts
- Why useful: good for tracking who is advancing engineered biologics and antibody programs
- Search for specific newsletters around biotech/clinical development
4) STAT biotech newsletters
- Best for: broad biotech and drug development updates
- Why useful: occasionally covers antibody engineering, immunotherapy, and biologics strategy
5) Fierce Biotech / Fierce Pharma
- Best for: industry pipeline and company news
- Why useful: easy-to-scan summaries of biologics, antibody-drug conjugates, and partnership activity
- They offer multiple free newsletter options
6) GEN (Genetic Engineering & Biotechnology News)
- Best for: biologics research, platform technologies, translational biotech
- Why useful: often covers protein engineering, next-gen antibodies, and therapeutic modalities
7) The Antibody Society journal/pipeline alerts
- If you want a more technical and structured pipeline view, this is especially relevant for:
- approved antibody therapeutics
- clinical-stage monoclonals
- bispecifics and related engineered formats
Useful broader biologics/pipeline newsletters
These are not antibody-only, but they’re good for pipeline examples:
- Evaluate Vantage / Evaluate Pharma
Strong for market and pipeline analysis of biologics - Scrip
Good for pharma industry pipeline, partnering, and R&D news - Nature Biotechnology newsletters
Good for protein engineering, platform papers, and translational advances - The Translational Scientist / Clinical trial newsletters
Helpful for linking research to development-stage assets
If you want the most relevant mix
For your use case, I’d start with:
- Antibody Society
- BioCentury
- Endpoints News
- GEN
- Fierce Biotech
That combination gives you:
- research depth
- pipeline visibility
- business/partnering context
- engineered biologics coverage
Tip: how to filter for protein-engineered therapies
When scanning newsletters, prioritize terms like:
- bispecific antibody
- multispecific
- Fc engineering
- half-life extension
- antibody-drug conjugate (ADC)
- fusion protein
- de novo protein
- affinity maturation
- conditional activation
- cytokine engineering
- protein scaffolds / binders
If you want, I can also make you a ranked list of the best free newsletters only, or a more academic list focused on therapeutic protein engineering papers and preclinical pipeline tracking.
Observation history
Unlock observation history
Create a free Obsurfable account to unlock historical responses, model comparisons, and deeper brand intelligence.
How did Obsurfable measure this prompt?
Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.
Which AI systems does Obsurfable collect answers from?
OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, and Meta AI.